225 related articles for article (PubMed ID: 20085229)
1. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing cefazolin.
Kodym A; Zawisza T; Buźka K; Kukuła H
Acta Pol Pharm; 2006; 63(3):225-34. PubMed ID: 20085229
[TBL] [Abstract][Full Text] [Related]
2. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing ceftazidime.
Kodym A; Zawisza T; Napierała B; Kukuła H
Acta Pol Pharm; 2006; 63(6):507-13. PubMed ID: 17438868
[TBL] [Abstract][Full Text] [Related]
3. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
Kodym A; Marcinkowski A; Kukuła H
Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical and microbiological properties of eye drops containing cefuroxime.
Kodym A; Zawisza T; Taberska J; Kukuła H
Acta Pol Pharm; 2006; 63(4):293-9. PubMed ID: 17203867
[TBL] [Abstract][Full Text] [Related]
5. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
Kodym A; Bilski P; Domańska A; Hełminiak Ł; Jabłońska M; Jachymska A
Acta Pol Pharm; 2012; 69(1):95-105. PubMed ID: 22574512
[TBL] [Abstract][Full Text] [Related]
6. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A; Wiśniewski A; Knioła D; Olejniczak M
Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
[TBL] [Abstract][Full Text] [Related]
7. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A; Hapka-Zmich D; Gołab M; Gwizdala M
Acta Pol Pharm; 2011; 68(1):99-107. PubMed ID: 21485707
[TBL] [Abstract][Full Text] [Related]
8. Technology of eye drops containing metronidazole.
Kodym A; Kaczyńska-Dyba E; Kubiak B; Kukuła H
Acta Pol Pharm; 2011; 68(1):109-14. PubMed ID: 21485708
[TBL] [Abstract][Full Text] [Related]
9. Stability of fortified cefazolin ophthalmic solutions prepared in artificial tears containing surfactant-based versus oxidant-based preservatives.
Rojanarata T; Tankul J; Woranaipinich C; Potawanich P; Plianwong S; Sakulma S; Saehuan C
J Ocul Pharmacol Ther; 2010 Oct; 26(5):485-90. PubMed ID: 20879806
[TBL] [Abstract][Full Text] [Related]
10. Stability of cefazolin sodium eye drops.
How TH; Loo WY; Yow KL; Lim LY; Chan EW; Ho PC; Chan SY
J Clin Pharm Ther; 1998 Feb; 23(1):41-7. PubMed ID: 9756111
[TBL] [Abstract][Full Text] [Related]
11. [Stability of cefazolin sodium as eyedrops in various solutions].
Yildirim N; Topbaş S; Usluer G; Ozgüneş I; Başmak H; Yurdakul S
Mikrobiyol Bul; 1991 Jul; 25(3):272-6. PubMed ID: 1762595
[TBL] [Abstract][Full Text] [Related]
12. Sterility of non-preservative eye drops.
Prabhasawat P; Chotikavanich S; Leelaporn A
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
[TBL] [Abstract][Full Text] [Related]
13. Stability of cefepime in aqueous eye drops.
Kodym A; Pawłowska M; Rumiński JK; Bartosińska A; Kieliba A
Pharmazie; 2011 Jan; 66(1):17-23. PubMed ID: 21391430
[TBL] [Abstract][Full Text] [Related]
14. Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles.
Ahmed I; Day P
Am J Hosp Pharm; 1987 Oct; 44(10):2287-90. PubMed ID: 3687969
[TBL] [Abstract][Full Text] [Related]
15. Stability and Sterility of Extemporaneously Prepared Nonpreserved Cefazolin, Ceftazidime, Vancomycin, Amphotericin B, and Methylprednisolone Eye Drops.
Ratprasatporn N; Wittayalertpanya S; Khemsri W; Chatsuwan T; Chongpison Y; Chamsai T; Wattanakijkarn M; Chansangpetch S
Cornea; 2019 Aug; 38(8):1017-1022. PubMed ID: 31090593
[TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Bozdağ S; Gümüş K; Gümüş O; Unlü N
Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
[TBL] [Abstract][Full Text] [Related]
17. Temperature-mediated absorption of phenylmercuric nitrate on polyethylene and polypropylene containers in chloramphenicol eye drops.
Charoo N; Chiew M; Tay A; Lian L
Cutan Ocul Toxicol; 2014 Sep; 33(3):242-6. PubMed ID: 24147942
[TBL] [Abstract][Full Text] [Related]
18. [Antimicrobial agents in eyedrops].
Sklubalová Z
Ceska Slov Farm; 2004 May; 53(3):107-16. PubMed ID: 15218731
[TBL] [Abstract][Full Text] [Related]
19. In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months.
Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
Cornea; 2010 Jul; 29(7):807-11. PubMed ID: 20489598
[TBL] [Abstract][Full Text] [Related]
20. Antifungal effect of ophthalmic preservatives phenylmercuric nitrate and benzalkonium chloride on ocular pathogenic filamentous fungi.
Xu Y; He Y; Li X; Gao C; Zhou L; Sun S; Pang G
Diagn Microbiol Infect Dis; 2013 Jan; 75(1):64-7. PubMed ID: 23102555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
